Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | -5.88% | -2.04% | +62.71% |
Apr. 25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
Apr. 02 | NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 25.12M 34.29M |
---|---|---|---|---|---|
Net income 2024 * | -4M -5.46M | Net income 2025 * | -4M -5.46M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.16
x | P/E ratio 2025 * |
-4.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.74% |
1 day | -1.92% | ||
1 week | +4.08% | ||
Current month | -1.92% | ||
1 month | -13.56% | ||
3 months | -27.14% | ||
6 months | +61.90% | ||
Current year | +72.88% |
Managers | Title | Age | Since |
---|---|---|---|
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Eran Ovadya
DFI | Director of Finance/CFO | - | 22-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Richardson
BRD | Director/Board Member | 78 | 22-01-02 |
Gadi Riesenfeld
BRD | Director/Board Member | 79 | 23-07-05 |
Yoram Drucker
CHM | Chairman | 59 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.48 | -5.88% | 34 394 |
24-06-03 | 0.51 | -1.92% | 10,863 |
24-05-31 | 0.52 | +1.96% | 4,000 |
24-05-30 | 0.51 | -3.77% | 24,000 |
24-05-29 | 0.53 | +8.16% | 14,101 |
Delayed Quote Toronto S.E., June 03, 2024 at 03:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.88% | 25.12M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.07% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- NRX Stock